Keywords: Bone/Skeletal, Hematology, Oncology
Motivation: Early relapse (ER) in MM leads to poor prognosis, making early identification of high-risk patients essential. Current models are limited by biopsy variability and high gene detection costs. A non-invasive ER prediction tool for MM is urgently needed.
Goal(s): Develop and validate a radiomics model combining MRI, clinical, and semantic features to predict ER in MM.
Approach: We used multicenter retrospective data and 5-fold cross-validation, evaluating performance on an external test set with ROC and decision curves.
Results: The model (T2 + SF + clinic) showed AUC of 0.856, good calibration, and high net benefit. ER patients had shorter PFS (P < 0.001).
Impact: Integrating imaging and semantic features improved model accuracy and interpretability, enabling early risk identification and supporting personalized MM treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords